// App-Quantinova.ai

DOP85 : Rising depression and antidepressant use amongst inflammatory bowel disease patients

Researchers

Presenter

  • J Blackwell

Principal Investigators

  • S Saxena

  • C Alexakis

  • E Cecil

  • A Bottle

  • I Petersen

  • M Hotopf

  • R Pollok

Medical Centers

  • St George's Healthcare NHS Trust, Gastroenterology, London, UK

  • Imperial College London, School of Public Health, London, UK

  • University College London, Epidemiology and Health Informatics, London, UK

  • Aarhus University, Section of Biostatistics, Aarhus, Denmark

  • Kings College London, Institute of Psychiatry, London, United Kingdom

Locations

  • United Kingdom

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Infectious Diseases (ID)

  • Genetic Disorder

  • Gastroenterology (GU)

Disease

  • Inflammatory bowel disease

  • Depression

Biomarkers

  • Adrenomedullin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved